Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis

2017422 citationsReviewbronze Open Access

Authors

Giovanni Musso · Ospedale Humanitas Gradenigo

Elena Paschetta · Ospedale Humanitas Gradenigo

Abstract

Pioglitazone use improves advanced fibrosis in NASH, even in patients without diabetes. Whether this finding translates to improvement in risk for clinical outcomes requires further study.

Topics & Keywords

Liver Disease Diagnosis and Treatment Hepatitis C virus research Liver Diseases and Immunity

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Internal Medicine

Volume 177, Issue 5, pp. 633-633

DOI: 10.1001/jamainternmed.2016.9607

Field-Weighted Citation Impact: 21.07